Activation of muscarinic acetylcholine receptors via their allosteric binding sites

Proceedings of the National Academy of Sciences of the United States of America

Volumn 93, Issue 16, 1996, Pages 8705-8709

  Jakubík, Jan ^a   Bačáková, Lucie ^a   Lisá, Věra ^a   El Fakahany, Esam E ^b   Tuček, Stanislav ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

alcuronium; cAMP; Chinese hamster ovary cells; G protein; inositol phosphates

Indexed keywords

ALCURONIUM; CARBACHOL; CYCLIC AMP; GALLAMINE; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL PHOSPHATE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC RECEPTOR; QUINUCLIDINYL BENZILATE; STRYCHNINE;

ALLOSTERISM; ANIMAL CELL; ARTICLE; BINDING SITE; CHO CELL; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

ALCURONIUM; ALLOSTERIC REGULATION; ANIMALS; CHO CELLS; CRICETINAE; CYCLIC AMP; GALLAMINE TRIETHIODIDE; GTP-BINDING PROTEINS; INOSITOL PHOSPHATES; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; PERIODICITY; QUINUCLIDINYL BENZILATE; RECEPTORS, MUSCARINIC; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; STRYCHNINE; TRANSFECTION;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS; STRYCHNOS TOXIFERA;

EID: 0029776693     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.93.16.8705     Document Type: Article

References (53)

1. Brown, J. H., ed. (1989) The Muscarinic Receptors (Humana, Clifton, NJ).
2. Caufield, M. P. (1993) Pharmacol. Ther. 58, 319-379.
3. Felder C. C. (1995) FASEB J. 9, 619-625.
4. Hulme, E. C., Birdsall, N. J. M. & Buckley, N. J. (1990) Annu. Rev. Pharmacol. Toxicol. 30, 633-673.
5. Wess, J., Liu, J., Blüml, K., Yun, J., Schöneberg, T. & Blin, N. (1995) in Molecular Mechanisms of Muscarinic Acetytcholine Receptor Function, ed. Wess, J. (Landes, Austin, TX), pp. 1-18.
6. Henis, Y. I., Kloog, Y. & Sokolovsky, M. (1989) in The Muscarinic Receptors, ed. Brown, J. H. (Humana, Clifton, NJ), pp. 377-418.
7. Lee, N. H. & El-Fakahany, E. E. (1991) Biochem. Pharmacol. 42, 199-205.
8. Tuček, S. & Proška, J. (1995) Trends Pharmacol. Sci. 16, 205-212.
9. Ellis, J. & Seidenberg, M. (1992) Mol. Pharmacol. 42, 638-641.
10. Waelbroeck, M. (1994) Mol. Pharmacol. 46, 685-692
11. Proška, J. & Tuček, S. (1995) Mol. Pharmacol. 48, 696-702.
12. Tuček S., Proška, J. & Jakubík, J. (1993) J. Neurochem. 61, S19.
13. Proška, J. & Tuček, S. (1994) Mol. Pharmacol. 45, 709-717.
14. Jakubík, J. & Tuček, S. (1994) J. Neurochem. 63, 1932-1940.
15. Jakubík, J. & Tuček, S. (1995) Eur. J. Pharmacol. 289, 311-319.
16. Leppik, R. A., Miller, R. C., Eck, M. & Paquet, J.-L. (1994) Mol. Pharmacol. 45, 983-990.
17. Jakubik, J., Bačáková, L., El-Fakahany, E. E. & Tuček, S. (1995) J. Pharmacol. Exp. Ther. 274, 1077-1083.
18. Matsui, H., Lazareno, S. & Birdsall, N. J. M. (1995) Mol. Pharmacol. 47, 88-98.
19. Buckley, N. J., Bonner, T. I., Buckley, C. M. & Brann, M. R. (1989) Mol. Pharmacol. 35, 469-476.
20. Zhu, S. Z., Wang, S. Z., Hu. J. & El-Fakahany, E. E. (1994) Mol. Pharmacol. 45, 517-523.
21. Jakubík, J., Bačáková, L., El-Fakahany, E. E. & Tuček, S. (1995) FEBS Lett. 377, 275-279.
22. Wang, S. Z. & El-Fakahany, E. E. (1993) J. Pharmacol. Exp. Ther. 266, 237-243.
23. Johnson, R. A., Alvarez, R. & Salomon, Y. (1994) Methods Enzymol. 238, 31-56.
24. Berridge, M. J., Downes, C. P. & Hanley, M. R. (1982) Biochem. J. 206, 584-594.
25. Tuček, S., Musílková, J., Nedoma, J., Proška, J., Shelkovnikov, S. & Vorlíček, J. (1990) Mol. Pharmacol. 38, 674-680.
26. Dong, G. Z., Haga, T., Itokawa, H. & Mizobe, F. (1995) Biomed. Res. 16, 327-335.
27. Dittman, A. H., Weber, J. P., Hinds, T. R., Choi, E.-J., Migeon, J. C., Nathanson, N. M. & Storm, D. R. (1994) Biochemistry 33, 943-951.
28. Migeon, J. C. & Nathanson, N. M. (1994) J. Biol. Chem. 269, 9767-9773.
29. Jones, S. V. P., Heilman, C. J. & Brann, M. R. (1991) Mol. Pharmacol. 40, 242-247.
30. Burford, N. T., Tobin, A. B. & Nahorski, S. R. (1995) J. Pharmacol. Exp. Ther. 274, 134-142.
31. Lazareno, S. & Birdsall, J. M. (1995) Mol. Pharmacol 48, 362-378.
32. Dong, G. Z., Kameyama, K., Rinken, A. & Haga, T. (1995) J. Pharmacol. Exp. Ther. 274, 378-384.
33. Dunlap, J. & Brown, J. H. (1983) Mol. Pharmacol. 24, 15-22.
34. Ellis, J., Huyler, J. & Brann, M. R. (1991) Biochem. Pharmacol. 42, 1927-1932.
35. Stockton, J. M., Birdsall, N. J. M., Burgen, A. S. V. & Hulme, E. C. (1983) Mol. Pharmacol. 23, 551-557.
36. Clark, A. L. & Mitchelson, F. (1976) Br. J. Pharmacol. 58, 323-331.
37. Kenakin, T. & Boselli, C. (1989) J. Pharmacol. Exp. Ther. 250, 944-952.
38. Dorofeeva, N. A., Shelkovnikov, S. A., Starshinova, L. A., Danilov, A. F., Nedoma, J. & Tuček, S. (1992) Naunyn-Schmiedebergs Arch. Pharmacol. 346, 383-390.
39. Ehlert, F. J. (1988) J. Pharmacol. Exp. Ther. 247, 596-602.
40. Burgen, A. S. V. (1981) Fed. Proc. 40, 2723-2728.
41. Kenakin, T., Morgan, P. & Lutz, M. (1995) Biochem. Pharmacol. 50, 17-26.
42. Leff, P. (1995) Trends Pharmacol. Sci. 16, 89-97.
43. Burgen, A. S. V. (1987) Br. J. Pharmacol. 92, 327-332.
44. Shiozaki, K. & Haga, T. (1992) Biochemistry 31, 10634-10642.
45. Kenakin, T. (1995) Trends Pharmacol. Sci. 16, 188-192.
46. Kenakin, T. (1995) Trends Pharmacol. Sci. 16, 232-238.
47. Gardner, B. (1995) Trends Pharmacol. Sci. 16, 259-260.
48. Hilf, G. & Jakobs, K. H. (1992) Eur. J. Pharmacol. 225, 245-252.
49. Hanf, R., Li, Y., Szabo, G. & Fischmeister, R. (1993) J. Physiol. (London) 461, 743-765.
50. Burstein, E. S., Spalding, T. A., Brauner-Osborne, H. & Brann, M. R. (1995) FEBS Lett. 363, 261-263.
51. Vogel, W. K., Mosser, V. A., Bulseco, D. A. & Schimerlik, M. I. (1995) J. Biol. Chem. 270, 15485-15493.
52. Högger, P., Shockley, M. S., Lameh, J. & Sadée, W. (1995) J. Biol. Chem. 270, 7405-7410.
53. Birdsall, N. J. M., Cohen, F., Lazareno, S. & Matsui, H. (1995) Biochem. Soc. Trans. 23, 108-111.